Sebastian Nijman, Scenic co-founder and CSO
Aiming to drug genetic modifiers, Roche-partnered biotech bags $31M to fuel a drive toward clinic
Over the past year and a half since Scenic Biotech signed its discovery pact with Roche’s Genentech, the partners have expanded the deal twice …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
